Form 4 for TNDM TANDEM DIABETES CARE INC
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-17 · accession 0001438133-22-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-05-19 | 2022-05-17 | TNDM | BLICKENSTAFF KIM D | Dir | S - Sale+OE | $92.91 | -10.8K | 205.2K | -5% | -$999.9K |
| DI | 2022-05-19 | 2022-05-17 | TNDM | BLICKENSTAFF KIM D | Dir | M - OptEx | $73.73 | +13.6K | 216.0K | +7% | +$999.9K |
| DM | 2022-05-19 | 2022-05-17+ | TNDM | BLICKENSTAFF KIM D | Dir | M - OptEx | $6.74 | +8,765 | 10.7K | +463% | +$59.0K |
| DM | 2022-05-19 | 2022-05-17+ | TNDM | BLICKENSTAFF KIM D | Dir | M - OptEx | $6.74 | +8,765 | 0 | New | +$59.0K |
| DI | 2022-05-19 | 2022-05-17 | TNDM | BLICKENSTAFF KIM D | Dir | M - OptEx | $73.73 | +13.6K | 0 | New | +$999.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-17 | S | D | 10,762 | $92.91 | 205,190 | I | — | — | |
| 2 | Common | Common Stock | 2022-05-17 | M | A | 13,562 | $73.73 | 215,952 | I | — | — | |
| 3 | Common | Common Stock | 2022-05-17 | M | A | 6,560 | $9.00 | 8,452 | D See Footnote | — | — | (F3) The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010. |
| 4 | Common | Common Stock | 2022-05-18 | M | A | 2,205 | $0.00 | 10,657 | D See Footnote | — | — | (F3) The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010. |
| 5 | Derivative | Restricted Stock Unit | 2022-05-18 | M | A | 2,205 | $0.00 | 0 | D | — · — to — | 2,205 Common Stock | (F7) Awarded on May 18, 2021 pursuant to the 2013 Plan, as amended, and the agreements related thereto. (F8) Each restricted stock (RSU) unit represents a contingent right to receive one share of common stock of the Company. (F9) Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan. |
| 6 | Derivative | Warrant | 2022-05-17 | M | A | 13,562 | $73.73 | 0 | I | $73.73 · 2022-05-17 to — | 13,562 Common Stock | (F6) The expiration dates for these warrants are May 25, 2022 (2,712 shares), and July 3, 2022 (10,850 shares). |
| 7 | Derivative | Stock Option | 2022-05-17 | M | A | 6,560 | $9.00 | 0 | D See Footnote | $9.00 · — to — | 6,560 Common Stock | (F3) The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010. (F4) The options vested as to twenty-five percent (25%) of the underlying shares on 5/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). (F5) The expiration date for these options is 10 years from the date of grant. |